Mesothelioma Research Today is a free monthly online journal that collates and summarizes the latest research about Mesothelioma, including details on asbestos, symptoms, treatment, causes.

Volume 1 (2005), Issue 10 (December)

1. Malignant pleural mesothelioma: a case report.
   J Manipulative Physiol Ther, 28(9): 724-9. [Abstract] [Full-text]
2. Mesothelioma from the patient's perspective.
   Hematol Oncol Clin North Am, 19(6): 1175-90, viii. [Abstract] [Full-text]
3. Gene therapy for malignant pleural mesothelioma.
   Hematol Oncol Clin North Am, 19(6): 1147-73, viii. [Abstract] [Full-text]
4. Antiangiogenic therapies for mesothelioma.
   Hematol Oncol Clin North Am, 19(6): 1137-45, viii. [Abstract] [Full-text]
5. An overview of chemotherapy for mesothelioma.
   Hematol Oncol Clin North Am, 19(6): 1117-36, vii. [Abstract] [Full-text]
6. Radiotherapy for mesothelioma.
   Hematol Oncol Clin North Am, 19(6): 1099-115, vii. [Abstract] [Full-text]
7. Multimodality treatments in the management of malignant pleural mesothelioma: an update.
   Hematol Oncol Clin North Am, 19(6): 1089-97, vii. [Abstract] [Full-text]
8. Nonpleural mesotheliomas: mesothelioma of the peritoneum, tunica vaginalis, and pericardium.
   Hematol Oncol Clin North Am, 19(6): 1067-87, vi. [Abstract] [Full-text]
9. The radiologic measurement of mesothelioma.
   Hematol Oncol Clin North Am, 19(6): 1053-66, vi. [Abstract] [Full-text]
10. Prognostic factors for mesothelioma.
    Hematol Oncol Clin North Am, 19(6): 1041-52, vi. [Abstract] [Full-text]
11. Detection of malignant mesothelioma in asbestos-exposed individuals: the potential role of soluble mesothelin-related protein.
    Hematol Oncol Clin North Am, 19(6): 1025-40, v. [Abstract] [Full-text]
12. Molecular biology of malignant mesothelioma: a review.
    Hematol Oncol Clin North Am, 19(6): 997-1023, v. [Abstract] [Full-text]
13. Benign multicystic peritoneal mesothelioma: cases reports in the family with diverticulosis and literature review.
    Int J Gynecol Cancer, 15(6): 1101-7. [Abstract] [Full-text]
14. Activation of tumor-associated macrophages by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid induces an effective CD8+ T-cell-mediated antitumor immune response in murine models of lung cancer and mesothelioma.
    Cancer Res, 65(24): 11752-61. [Abstract] [Full-text]
15. The diagnostic utility of immunohistochemistry and electron microscopy in distinguishing between peritoneal mesotheliomas and serous carcinomas: a comparative study.
    Mod Pathol, 19(1): 34-48. [Abstract] [Full-text]
16. Spontaneous pregnancy following cytoreduction with peritonectomy and hyperthermic intraperitoneal chemotherapy.
    Gynecol Oncol, 100(1): 198-200. [Abstract] [Full-text]
17. Multimodality approach in management of malignant pleural mesothelioma.
    Eur J Cardiothorac Surg, 29(1): 14-9. [Abstract] [Full-text]

© 2005-2008 Mesothelioma Research Today. All Rights Reserved.